Mark Nimmer
Impact in
- Pharmacology top 5%
- Drug-Induced Adverse Reactions
- Genetics top 10%
- Hemoglobinopathies and Related Disorders
Papers in
- Co-authors
- David C. Brousseau (20 shared papers)Pippa Simpson (5 shared papers)David Vyles (3 shared papers)Asriani Chiu (2 shared papers)Julie A. Panepinto (6 shared papers)Ann B. Nattinger (1 shared paper)Ann Greer (1 shared paper)Raymond G. Hoffmann (3 shared papers)
- Journals
- Injury Epidemiology (4 papers)PEDIATRICS (4 papers)Pediatric Blood & Cancer (4 papers)Pediatric Emergency Care (3 papers)Blood (2 papers)
- Partner nations
- United StatesIreland
In The Last Decade
Mark Nimmer
30 papers receiving 472 citations
Peers
Comparison fields: 5 of 50
- Pharmacology 157
- Genetics 94
- Immunology and Allergy 45
- Emergency Medicine 54
- Dermatology 39
Countries citing papers authored by Mark Nimmer
This map shows the geographic impact of Mark Nimmer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Nimmer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Nimmer more than expected).
Fields of papers citing papers by Mark Nimmer
This network shows the impact of papers produced by Mark Nimmer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Nimmer. The network helps show where Mark Nimmer may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Nimmer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 103 | |
| 2 | 2017 | 74 | |
| 3 | 2011 | 58 | |
| 4 | 2011 | 51 | |
| 5 | 2009 | 27 | |
| 6 | 2016 | 26 | |
| 7 | 2018 | 16 | |
| 8 | 2010 | 14 | |
| 9 | 2022 | 12 | |
| 10 | 2020 | 11 | |
| 11 | 2012 | 10 | |
| 12 | 2020 | 10 | |
| 13 | 2014 | 9 | |
| 14 | 2021 | 8 | |
| 15 | 2021 | 7 | |
| 16 | 2021 | 6 | |
| 17 | 2018 | 6 | |
| 18 | 2016 | 5 | |
| 19 | 2023 | 5 | |
| 20 | 2023 | 5 |
About Mark Nimmer
Mark Nimmer is a scholar working on Genetics, Health, Pharmacology, Pediatrics, Perinatology and Child Health and Epidemiology, having authored 33 papers that have together received 484 indexed citations. Recurring topics across this work include Hemoglobinopathies and Related Disorders (9 papers), Gun Ownership and Violence Research (3 papers), Drug-Induced Adverse Reactions (3 papers), Emergency and Acute Care Studies (3 papers), Influenza Virus Research Studies (3 papers), Pharmacological Effects and Toxicity Studies (2 papers), Folate and B Vitamins Research (1 paper) and Ethics and Legal Issues in Pediatric Healthcare (1 paper). The work is most often cited by research in Pharmacology (157 citations), Genetics (94 citations), Immunology and Allergy (45 citations), Emergency Medicine (54 citations) and Dermatology (39 citations). Mark Nimmer has collaborated with scholars based in United States and Ireland. Frequent co-authors include David C. Brousseau, Pippa Simpson, David Vyles, Asriani Chiu, Julie A. Panepinto, Ann B. Nattinger, Ann Greer, Raymond G. Hoffmann, Ke Yan and Amanda M. Brandow. Their work appears in journals such as Injury Epidemiology, PEDIATRICS, Pediatric Blood & Cancer, Pediatric Emergency Care and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.